123 related articles for article (PubMed ID: 38082439)
1. USP7 promotes non-small-cell lung cancer cell glycolysis and survival by stabilizing and activating c-Abl.
He Y; Jiang S; Zhong Y; Wang X; Cui Y; Liang J; Sun Y; Zhu Z; Huang Z; Mao X
Clin Transl Med; 2023 Dec; 13(12):e1509. PubMed ID: 38082439
[TBL] [Abstract][Full Text] [Related]
2. USP7 promotes cell proliferation through the stabilization of Ki-67 protein in non-small cell lung cancer cells.
Zhang C; Lu J; Zhang QW; Zhao W; Guo JH; Liu SL; Wu YL; Jiang B; Gao FH
Int J Biochem Cell Biol; 2016 Oct; 79():209-221. PubMed ID: 27590858
[TBL] [Abstract][Full Text] [Related]
3. The m6A demethylase FTO promotes the growth of lung cancer cells by regulating the m6A level of USP7 mRNA.
Li J; Han Y; Zhang H; Qian Z; Jia W; Gao Y; Zheng H; Li B
Biochem Biophys Res Commun; 2019 May; 512(3):479-485. PubMed ID: 30905413
[TBL] [Abstract][Full Text] [Related]
4. The deubiquitinase USP7 promotes HNSCC progression via deubiquitinating and stabilizing TAZ.
Li J; Dai Y; Ge H; Guo S; Zhang W; Wang Y; Liu L; Cheng J; Jiang H
Cell Death Dis; 2022 Aug; 13(8):677. PubMed ID: 35931679
[TBL] [Abstract][Full Text] [Related]
5. A feedforward circuit shaped by ECT2 and USP7 contributes to breast carcinogenesis.
Zhang Q; Cao C; Gong W; Bao K; Wang Q; Wang Y; Bi L; Ma S; Zhao J; Liu L; Tian S; Zhang K; Yang J; Yao Z; Song N; Shi L
Theranostics; 2020; 10(23):10769-10790. PubMed ID: 32929379
[No Abstract] [Full Text] [Related]
6. USP7 mediates TRAF4 deubiquitination to facilitate the malignant phenotype of ovarian cancer via the RSK4/PI3K/AKT axis.
Wang Y; Luo X; Wu N; Liao Q; Wang J
J Cancer Res Ther; 2023 Feb; 19(1):97-107. PubMed ID: 37006049
[TBL] [Abstract][Full Text] [Related]
7. WDR79 promotes the proliferation of non-small cell lung cancer cells via USP7-mediated regulation of the Mdm2-p53 pathway.
Sun Y; Cao L; Sheng X; Chen J; Zhou Y; Yang C; Deng T; Ma H; Feng P; Liu J; Tan W; Ye M
Cell Death Dis; 2017 Apr; 8(4):e2743. PubMed ID: 28406480
[TBL] [Abstract][Full Text] [Related]
8. Suppression of USP7 induces BCR-ABL degradation and chronic myelogenous leukemia cell apoptosis.
Jiang S; Wang X; He Y; Huang H; Cao B; Zhang Z; Liu J; Wang Q; Huang Z; Mao X
Cell Death Dis; 2021 May; 12(5):456. PubMed ID: 33963175
[TBL] [Abstract][Full Text] [Related]
9. USP7 promotes cervical cancer progression by stabilizing MTDH expression through deubiquitination.
Wang N; Xu J; Wang Y; Zhang X; Zhang H
J Cancer Res Clin Oncol; 2024 Apr; 150(4):196. PubMed ID: 38625581
[TBL] [Abstract][Full Text] [Related]
10. Deubiquitylation and stabilization of ARMC5 by ubiquitin-specific processing protease 7 (USP7) are critical for RCC proliferation.
Yan G; Liu N; Tian J; Fu Y; Wei W; Zou J; Li S; Wang Q; Li K; Wang J
J Cell Mol Med; 2021 Mar; 25(6):3149-3159. PubMed ID: 33544460
[TBL] [Abstract][Full Text] [Related]
11. LncRNA HOTAIRM1 knockdown inhibits cell glycolysis metabolism and tumor progression by miR-498/ABCE1 axis in non-small cell lung cancer.
Chen D; Li Y; Wang Y; Xu J
Genes Genomics; 2021 Feb; 43(2):183-194. PubMed ID: 33537917
[TBL] [Abstract][Full Text] [Related]
12. USP7 overexpression predicts a poor prognosis in lung squamous cell carcinoma and large cell carcinoma.
Zhao GY; Lin ZW; Lu CL; Gu J; Yuan YF; Xu FK; Liu RH; Ge D; Ding JY
Tumour Biol; 2015 Mar; 36(3):1721-9. PubMed ID: 25519684
[TBL] [Abstract][Full Text] [Related]
13. ANXA1-derived peptide for targeting PD-L1 degradation inhibits tumor immune evasion in multiple cancers.
Yu ZZ; Liu YY; Zhu W; Xiao D; Huang W; Lu SS; Yi H; Zeng T; Feng XP; Yuan L; Qiu JY; Wu D; Wen Q; Zhou JH; Zhuang W; Xiao ZQ
J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 37001908
[TBL] [Abstract][Full Text] [Related]
14. Stabilization of KPNB1 by deubiquitinase USP7 promotes glioblastoma progression through the YBX1-NLGN3 axis.
Li J; Zhang B; Feng Z; An D; Zhou Z; Wan C; Hu Y; Sun Y; Wang Y; Liu X; Wei W; Yang X; Meng J; Che M; Sheng Y; Wu B; Wen L; Huang F; Li Y; Yang K
J Exp Clin Cancer Res; 2024 Jan; 43(1):28. PubMed ID: 38254206
[TBL] [Abstract][Full Text] [Related]
15. Serum Exosomes-Based Biomarker circ_0008928 Regulates Cisplatin Sensitivity, Tumor Progression, and Glycolysis Metabolism by miR-488/
Shi Q; Ji T; Ma Z; Tan Q; Liang J
Cancer Biother Radiopharm; 2023 Oct; 38(8):558-571. PubMed ID: 33661058
[No Abstract] [Full Text] [Related]
16. miR-206 regulates non-small-cell lung cancer cell aerobic glycolysis by targeting hexokinase 2.
Jia KG; Feng G; Tong YS; Tao GZ; Xu L
J Biochem; 2020 Apr; 167(4):365-370. PubMed ID: 31742336
[TBL] [Abstract][Full Text] [Related]
17. The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival.
He Y; Wang S; Tong J; Jiang S; Yang Y; Zhang Z; Xu Y; Zeng Y; Cao B; Moran MF; Mao X
J Biol Chem; 2020 Feb; 295(7):2084-2096. PubMed ID: 31822558
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-induced lncRNA-AC020978 promotes proliferation and glycolytic metabolism of non-small cell lung cancer by regulating PKM2/HIF-1α axis.
Hua Q; Mi B; Xu F; Wen J; Zhao L; Liu J; Huang G
Theranostics; 2020; 10(11):4762-4778. PubMed ID: 32308748
[No Abstract] [Full Text] [Related]
19. Arginine methylation-dependent cGAS stability promotes non-small cell lung cancer cell proliferation.
Liu X; Zheng W; Zhang L; Cao Z; Cong X; Hu Q; Hou J; Jin X; Yuan Q; Lin L; Tan J; Lu J; Zhang Y; Zhang N
Cancer Lett; 2024 Apr; 586():216707. PubMed ID: 38331088
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of miR-214 inhibits proliferation and glycolysis in non-small-cell lung cancer cells via down-regulating the expression of hexokinase 2 and pyruvate kinase isozyme M2.
Zhang K; Zhang M; Jiang H; Liu F; Liu H; Li Y
Biomed Pharmacother; 2018 Sep; 105():545-552. PubMed ID: 29886375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
